Moderna launches mRNA Ebola vaccine trial amid Congo outbreak

Moderna has initiated a Phase 1 clinical trial for an experimental mRNA vaccine targeting Ebola virus, authorized by Health Canada and supported by CEPI funding. The trial aims to address an ongoing outbreak in the Democratic Republic of Congo that has caused thousands of confirmed cases and deaths.